Experience in personifying the standard treatment of patients with hemophilia A: results of a multicenter Russian open-labeled prospective study evaluating the use of haemoctin
Aim. To evaluate the clinical efficiency, tolerability, safety, and immunogenicity of replacement therapy with haemoctin SDH (Biotest Pharma GmbH, Germany) in pretreated patients with hemophilia A (HA). Subjects and methods. The pretreated patients (n = 140) with varying GA from 12 regions of the Ru...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2010-04-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/30603 |